ONCE-YEARLY ZOLEDRONIC ACID 5 MG INFUSION FOR TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: EFFECTS ON FRACTURE INCIDENCE IN PATIENT SUBGROUPS FROM THE HORIZON-PFT STUDY

被引：0
|
作者：
Eastell, Richard [1 ]
Black, Dennis M. [3 ]
Boonen, Steven [2 ]
McLellan, Alastair R. [4 ]
Cummings, Steven R. [3 ]
Delmas, Pierre D. [5 ,6 ]
Palermo, Lisa [3 ]
Mesenbrink, Peter [7 ]
Cauley, Jane A. [8 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Katholieke Univ Leuven, Leuven, Belgium
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[5] INSERM, Res U831, F-69008 Lyon, France
[6] Univ Lyon, Lyon, France
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Univ Pittsburgh, Pittsburgh, PA USA
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I105 / I105
页数：1
相关论文
共 50 条
  • [1] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Black, D.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J.
    Cosman, F.
    Lakatos, R.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Cummings, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 101 - 101
  • [2] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, P.
    Delmas, R.
    Sellmeyer, D.
    Abrams, K.
    Hu, H.
    Lippuner, K.
    Boonen, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 524
  • [3] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, Paul
    Sellmeyer, Deborah
    Boonen, Steven R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S227 - S228
  • [4] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: results from HORIZON-PFT
    Miller, P.
    Sellmeyer, D.
    Boonen, S.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S129 - S130
  • [5] Effect of Once-Yearly Zoledronic Acid 5 mg Infusion on Fracture Incidence in Postmenopausal Osteoporosis: Subgroup Analysis of the Horizon PFT Study
    Eastell, R.
    Black, D. M.
    Boonen, S.
    Cummings, S. R.
    Delmas, P. D.
    Palermo, L.
    Mesenbrink, P.
    Cauley, J. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S9 - S9
  • [6] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with Osteoporosis: Results from HORIZON-PFT.
    Black, D.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J.
    Cosman, F.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Cummings, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S174 - S175
  • [7] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: data from HORIZON-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S130 - S131
  • [8] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S. R.
    Cosman, F.
    Eastell, R.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S29 - S29
  • [9] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-pft
    Delmas, P.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eriksen, E. F.
    Mesenbrink, R.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [10] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, Pierre
    Bauer, Douglas
    Black, Dennis
    Boonen, Steven R.
    Cosman, Felicia
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S214 - S215
12345